Correlation Between Scpharmaceuticals and Amicus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Amicus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Amicus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Amicus Therapeutics, you can compare the effects of market volatilities on Scpharmaceuticals and Amicus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Amicus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Amicus Therapeutics.
Diversification Opportunities for Scpharmaceuticals and Amicus Therapeutics
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Scpharmaceuticals and Amicus is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Amicus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amicus Therapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Amicus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amicus Therapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Amicus Therapeutics go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Amicus Therapeutics
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Amicus Therapeutics. In addition to that, Scpharmaceuticals is 1.68 times more volatile than Amicus Therapeutics. It trades about -0.06 of its total potential returns per unit of risk. Amicus Therapeutics is currently generating about -0.06 per unit of volatility. If you would invest 1,385 in Amicus Therapeutics on August 25, 2024 and sell it today you would lose (419.00) from holding Amicus Therapeutics or give up 30.25% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Amicus Therapeutics
Performance |
| Timeline |
| Scpharmaceuticals |
| Amicus Therapeutics |
Scpharmaceuticals and Amicus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Amicus Therapeutics
The main advantage of trading using opposite Scpharmaceuticals and Amicus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Amicus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amicus Therapeutics will offset losses from the drop in Amicus Therapeutics' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Amicus Therapeutics vs. Eliem Therapeutics | Amicus Therapeutics vs. HCW Biologics | Amicus Therapeutics vs. RenovoRx | Amicus Therapeutics vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |